Abstract
Purpose
MRI-based screening in women with a ≥ 25% lifetime risk of breast cancer , but no identifiable genetic mutations may be associated with false positives. This study examined the psychological impact of abnormal screens and biopsies in non-mutation carriers participating in high-risk screening with no personal history of breast cancer.
Methods
Non-mutation carriers participating in the High-Risk Ontario Breast Screening Program at two sites were mailed demographic surveys, psychological scales, and chart review consent. Scales included the Consequences of Screening in Breast Cancer questionnaire, Lerman Breast Cancer Worry Scale, and Worry Interference Scale. Missing data were managed with multiple imputation. Multivariable regression was used to assess whether abnormal screens or biopsies were associated with adverse psychological effects.
Results
After contacting 465 participants, 169 non-mutation carriers were included. Median age was 46 years (range 30–65). Over a median 3 years of screening, 63.9% of women experienced at least one abnormal screen, and 24.9% underwent biopsies. Statements relating to cancer worry/anxiety scored highest, with 19.5% indicating they worried “a lot”. Higher scores among anxiety-related statements were strongly associated with higher dejection scores. Overall, coping and daily functioning were preserved. Women indicated some positive reactions to screening, including improved existential values and reassurance they do not have breast cancer. Abnormal screens and biopsies were not significantly associated with any psychological scale, even after adjustment for patient characteristics.
Conclusion
Non-mutation carriers undergoing MRI-based screening had considerable baseline anxiety and cancer worry, although daily functioning was not impaired. Abnormal screens and biopsies did not appear to have adverse psychological effects.
Similar content being viewed by others
Data availability
Due to the nature of this research, participants of this study did not explicitly agree for their data to be shared publicly, so supporting data are not available.
Code availability
Available upon request.
References
Warner E, Messersmith H, Causer P et al (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671–679. https://doi.org/10.7326/0003-4819-148-9-200805060-00007
Granader EJ, Dwamena B, Carlos RC (2008) MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach. Acad Radiol 15:1590–1595. https://doi.org/10.1016/j.acra.2008.06.006
Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89. https://doi.org/10.3322/canjclin.57.2.75
(2017) Breast Cancer Screening for Women at High Risk. In: Cancer Care Ontario. https://www.cancercareontario.ca/en/guidelines-advice/cancer-continuum/screening/breast-cancer-high-risk-women. Accessed 20 Jan 2020
Kuhl CK, Schmutzler RK, Leutner CC et al (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215:267–279. https://doi.org/10.1148/radiology.215.1.r00ap01267
Warner E, Plewes DB, Shumak RS et al (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–3531. https://doi.org/10.1200/JCO.2001.19.15.3524
(2017) High Risk Ontario Breast Screening Program FAQs for Healthcare Providers. In: Cancer Care Ontario. https://www.cancercareontario.ca/en/guidelines-advice/cancer-continuum/screening/breast-cancer-high-risk-women/faqs-for-healthcare-providers. Accessed 10 Jun 2020
Chiarelli AM, Blackmore KM, Muradali D et al (2019) Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djz079
Brett J, Bankhead C, Henderson B et al (2005) The psychological impact of mammographic screening. A Syst Rev Psycho-Oncol 14:917–938. https://doi.org/10.1002/pon.904
Brewer NT, Salz T, Lillie SE (2007) Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 146:502–510. https://doi.org/10.7326/0003-4819-146-7-200704030-00006
Bond M, Pavey T, Welch K et al (2013) Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess 17(1–170):v–vi. https://doi.org/10.3310/hta17130
Salz T, Richman AR, Brewer NT (2010) Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 19:1026–1034. https://doi.org/10.1002/pon.1676
Maxwell JR, Bugbee ME, Wellisch D et al (2000) Imaging-guided core needle biopsy of the breast: study of psychological outcomes. Breast J 6:53–61. https://doi.org/10.1046/j.1524-4741.2000.98079.x
Miller SJ, Sohl SJ, Schnur JB et al (2014) Pre-biopsy psychological factors predict patient biopsy experience. Int J Behav Med 21:144–148. https://doi.org/10.1007/s12529-012-9274-x
Steffens RF, Wright HR, Hester MY, Andrykowski MA (2011) Clinical, demographic, and situational factors linked to distress associated with benign breast biopsy. J Psychosoc Oncol 29:35–50. https://doi.org/10.1080/07347332.2011.534024
Spiegel TN, Esplen MJ, Hill KA et al (2011) Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance. Breast 20:424–430. https://doi.org/10.1016/j.breast.2011.04.004
Bakker MF, de Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381:2091–2102. https://doi.org/10.1056/NEJMoa1903986
Longo DL (2019) Detecting breast cancer in women with dense breasts. N Engl J Med 381:2169–2170. https://doi.org/10.1056/NEJMe1912943
Korenstein D (2018) Wise guidance and its challenges: the new Canadian recommendations on breast cancer screening. CMAJ 190:E1432–E1433. https://doi.org/10.1503/cmaj.181538
Spak DA, Plaxco JS, Santiago L et al (2017) BI-RADS® fifth edition: a summary of changes. Diagn Interv Imaging 98:179–190. https://doi.org/10.1016/j.diii.2017.01.001
Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H (2016) A pictorial review of changes in the BI-RADS fifth edition. Radiographics 36:623–639. https://doi.org/10.1148/rg.2016150178
Brodersen J, Thorsen H (2008) Consequences of screening in breast cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care 26:251–256. https://doi.org/10.1080/02813430802542508
Brodersen J, Thorsen H, Kreiner S (2007) Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 10:294–304. https://doi.org/10.1111/j.1524-4733.2007.00184.x
Brodersen J, Siersma VD (2013) Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 11:106–115. https://doi.org/10.1370/afm.1466
Brodersen J, Thorsen H, Cockburn J (2004) The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen 11:39–44. https://doi.org/10.1177/096914130301100109
Cockburn J, De Luise T, Hurley S, Clover K (1992) Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 34:1129–1134. https://doi.org/10.1016/0277-9536(92)90286-y
Lerman C, Trock B, Rimer BK et al (1991) Psychological side effects of breast cancer screening. Health Psychol 10:259
Trask PC, Paterson AG, Wang C et al (2001) Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology 10:349–360. https://doi.org/10.1002/pon.510
Rubin DB (2004) Multiple imputation for nonresponse in surveys. Wiley
van Dooren S, Rijnsburger AJ, Seynaeve C et al (2003) Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer. Community Genet 6:235–241. https://doi.org/10.1159/000079385
Rijnsburger AJ, Essink-Bot ML, van Dooren S et al (2004) Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 91:69–76. https://doi.org/10.1038/sj.bjc.6601912
Warner E (2004) Intensive radiologic surveillance: a focus on the psychological issues. Ann Oncol 15(Suppl 1):I43–I47. https://doi.org/10.1093/annonc/mdh657
den Heijer M, Seynaeve C, Vanheusden K et al (2013) Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile. Psychooncology 22:598–604. https://doi.org/10.1002/pon.3039
Brain K, Henderson BJ, Tyndel S et al (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 17:1180–1188
Henderson BJ, Tyndel S, Brain K et al (2008) Factors associated with breast cancer-specific distress in younger women participating in a family history mammography screening programme. Psychooncology 17:74–82
Tyndel S, Austoker J, Henderson BJ et al (2007) What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol 25:3823–3830
Portnoy DB, Loud JT, Han PK et al (2015) Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers. Health Psychol 34:709
O’Neill SM, Rubinstein WS, Sener SF et al (2009) Psychological impact of recall in high-risk breast MRI screening. Breast Cancer Res Treat 115:365
Schroeder D, Duggleby W, Cameron BL (2017) Moving in and out of the what-ifs: the experiences of unaffected women living in families where a breast cancer 1 or 2 genetic mutation was not found. Cancer Nurs 40:386–393. https://doi.org/10.1097/NCC.0000000000000438
Brédart A, Kop J-L, Fall M et al (2012) Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography. Psychooncology 21:1185–1194
Visser A, Van Laarhoven HW, Woldringh GH et al (2016) Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: a randomized controlled trial. Acta Oncol 55:178–187
Bennett P, Phelps C, Brain K et al (2007) A randomized controlled trial of a brief self-help coping intervention designed to reduce distress when awaiting genetic risk information. J Psychosom Res 63:59–64
McKinnon W, Naud S, Ashikaga T et al (2007) Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. J Genet Couns 16:433–456
White VM, Young M-A, Farrelly A et al (2014) Randomized controlled trial of a telephone-based peer-support program for women carrying a BRCA1 or BRCA2 mutation: impact on psychological distress. J Clin Oncol 32:4073–4080
Esplen MJ, Hunter J, Leszcz M et al (2004) A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 101:2327–2340
Prospero L, Seminsky M, Honeyford J et al (2001) Support groups for people carrying a BRCA mutation. CMAJ 165:740–742
Funding
Cancer Care Ontario, Achieving Excellence in Cancer Care Project Award (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The Research Ethics Boards at St. Michael’s Hospital (#15-168) and Sunnybrook Health Sciences Center (#397-2016) reviewed and approved this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Castelo, M., Brown, Z., D’Abbondanza, J.A. et al. Psychological consequences of MRI-based screening among women with strong family histories of breast cancer. Breast Cancer Res Treat 189, 497–508 (2021). https://doi.org/10.1007/s10549-021-06300-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-021-06300-w